PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F0GAB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $624,234
Award facts
- Contract value 100% obligated
- $624,234.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $624,234.36 by the Defense Logistics Agency's Medical Supply Chain on May 23, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award procedures. Performance is scheduled for completion by May 27, 2025, with work to be conducted at the company's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
The delivery order supports the Defense Logistics Agency's military and veteran healthcare pharmaceutical supply mission. AmerisourceBergen's broader IDC encompasses a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, specialized treatments for conditions including diabetes, neurological disorders, and pain management, as well as medical devices and associated supplies. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains and serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. DLA plans to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as one of several key providers in this strategic initiative.
Quick answers
Who was awarded contract SPE2D825F0GAB?
SPE2D825F0GAB was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on May 23, 2025.
How much is contract SPE2D825F0GAB worth?
The government has obligated $624,234 on SPE2D825F0GAB.
Is contract SPE2D825F0GAB an order under another contract?
Yes. SPE2D825F0GAB is a delivery order under SPE2DX22D0059, an indefinite delivery contract.
Was contract SPE2D825F0GAB competed?
The extent of competition for SPE2D825F0GAB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award